Multiple Sclerosis: Aging

Multiple Sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research MS and aging.

February 24, 2021

Susceptibility-weighted Imaging: Technical Essentials and Clinical Neurologic Applications.

Radiology
Sven HallerFrederik Barkhof
February 21, 2021

Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians?

Multiple Sclerosis and Related Disorders
Sharon LynchJared Bruce
February 18, 2021

Considering patient age when treating multiple sclerosis across the adult lifespan.

Expert Review of Neurotherapeutics
Dejan JakimovskiBianca Weinstock-Guttman
February 14, 2021
Review
Open Access

Multiple sclerosis and aging: comorbidity and treatment challenges.

Multiple Sclerosis and Related Disorders
Aiora OstolazaTeresa Ayuso
February 12, 2021
Review
Open Access

Nutraceuticals against Oxidative Stress in Autoimmune Disorders.

Antioxidants
Carmen MannucciSebastiano Gangemi
February 12, 2021
Review

Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.

Multiple Sclerosis and Related Disorders
Amirreza NaseriMahnaz Talebi
February 9, 2021
Open Access

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials.

Therapeutic Advances in Neurological Disorders
Yinan ZhangOlaf Stϋve
February 7, 2021
Open Access

Leukocyte Telomere Length in Patients with Multiple Sclerosis and Its Association with Clinical Phenotypes.

Molecular Neurobiology
M. HeckerU. K. Zettl
February 6, 2021
Review
Open Access

Mechanistic new insights of flavonols on neurodegenerative diseases.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Muhammad Shoaib TahirWei Zhang
February 6, 2021
Review
Open Access

Evidence and perspectives of cell senescence in neurodegenerative diseases.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Zizhen SiXidi Wang
February 2, 2021
Preprint
Open Access

Increasing age is independently associated with higher free water in non-active MS brain - A multi-compartment analysis using FAST-T2

BioRxiv : the Preprint Server for Biology
L. ZhouThanh D. Nguyen
February 2, 2021
Open Access

A Multidimensional Virtual Reality Neurorehabilitation Approach to Improve Functional Memory: Who Is the Ideal Candidate?

Frontiers in Neurology
Sonia Di TellaFrancesca Baglio
January 31, 2021
Review
Open Access

Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease.

Pharmaceuticals
Jacob KosyakovskyLeah R Hanson
January 26, 2021
Review
Open Access

An "Outside-In" and "Inside-Out" Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative Diseases.

Frontiers in Cellular Neuroscience
B Paul MorganValeria Ramaglia
January 23, 2021
Open Access

SVIP is a molecular determinant of lysosomal dynamic stability, neurodegeneration and lifespan.

Nature Communications
Alyssa E JohnsonGraeme W Davis
January 22, 2021

MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis.

Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
Mattia RossoTanuja Chitnis
January 17, 2021
Open Access

Changes in the Oligodendrocyte Progenitor Cell Proteome with Ageing

Molecular & Cellular Proteomics : MCP
Alerie G de la FuenteRobin J M Franklin
January 9, 2021

Effects of dietary restriction on neuroinflammation in neurodegenerative diseases

The Journal of Experimental Medicine
Luigi FontanaLaura Piccio
January 9, 2021
Open Access

Exifone Is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration.

ACS Chemical Neuroscience
Debasis PatnaikStephen J Haggarty

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis-and-aging/cce082e1-73b4-435d-b61a-42ded6bef250